Abeona Therapeutics Inc vs Microchip Technology Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Microchip Technology Inc. trades at $82.15 (market cap $43.99B). The key difference: Microchip Technology Inc. is far larger — about 104.4× Abeona Therapeutics Inc's market cap, and Microchip Technology Inc. pays a 2.25% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MCHP | |
|---|---|---|
Market Cap | $421.19M | $43.99B |
Sector | Health | Technology |
52-Week High | $7.45 | $102.97 |
52-Week Low | $4.17 | $49.02 |
Enterprise Value | $276.10M | $49.12B |
Dividend Yield | — | 2.25% |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →